Phytonadione Injection, Emulsion
NDC Package 81607-020-02

11-digit billing NDC: 81607002002

Package Information

Phytonadione injection is dilute phytonadione injectable emulsion with 0.9% Sodium Chloride Injection, 5% Dextrose Injection, or 5% Dextrose and Sodium Chloride Injection.When diluted, start administration of phytonadione injectable emulsion immediately after dilution. This formulation utilizes a injection, emulsion delivery system. Marketed by Orbicular Pharmaceutical Technologies Private Limited, this product is identified by NDC 81607-020 and is authorized under FDA application ANDA216298.

Identification & Billing

NDC Package Code
81607-020-02
Package Description
10 CARTON in 1 CARTON / 1 BLISTER PACK in 1 CARTON (81607-020-01) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE
Product Code
11-Digit Billing Format
81607002002
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Phytonadione
Non-Proprietary Name
Phytonadione
Substance Name
Phytonadione
Dosage Form
Injection, Emulsion - An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
Usage Information
Dilute phytonadione injectable emulsion with 0.9% Sodium Chloride Injection, 5% Dextrose Injection, or 5% Dextrose and Sodium Chloride Injection.When diluted, start administration of phytonadione injectable emulsion immediately after dilution. Discard unused portions of diluted solution as well as unused contents of the prefilled syringe. Protect phytonadione injectable emulsion from light at all times. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Regulatory & Marketing

Labeler Name
Orbicular Pharmaceutical Technologies Private Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA216298
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-24-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81607-020-02 identifies a specific commercial package of 10 carton in 1 carton / 1 blister pack in 1 carton (81607-020-01) / 1 syringe in 1 blister pack / .5 ml in 1 syringe of Phytonadione, a human prescription drug labeled by Orbicular Pharmaceutical Technologies Private Limited. This injection, emulsion is formulated for intramuscular; intravenous; subcutaneous use and contains phytonadione as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Orbicular Pharmaceutical Technologies Private Limited on March 24, 2026. The current certification is valid through December 31, 2027.

How is this Orbicular Pharmaceutical Technologies Private Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81607002002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81607-020-02
11-Digit CMS (5-4-2)
81607-0020-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.